Genetic variation in the prostaglandin E2 pathway is associated with primary graft dysfunction.
about
Pharmacogenomics of Prostaglandin and Leukotriene ReceptorsDesign and Implementation of the International Genetics and Translational Research in Transplantation NetworkOxidant stress regulatory genetic variation in recipients and donors contributes to risk of primary graft dysfunction after lung transplantation.Protein Quantitative Trait Loci Analysis Identifies Genetic Variation in the Innate Immune Regulator TOLLIP in Post-Lung Transplant Primary Graft Dysfunction RiskThe relationship between plasma lipid peroxidation products and primary graft dysfunction after lung transplantation is modified by donor smoking and reperfusion hyperoxia.Effects of intraoperative inhaled iloprost on primary graft dysfunction after lung transplantation: A retrospective single center study.Role of genetics in lung transplant complications.Bone disease in cystic fibrosis: new pathogenic insights opening novel therapies.Peripheral Blood Gene Expression Changes Associated With Primary Graft Dysfunction After Lung Transplantation.Primary graft dysfunction: pathophysiology to guide new preventive therapies.Quantitative Evidence for Revising the Definition of Primary Graft Dysfunction After Lung Transplant.Human neutrophils can mimic myeloid-derived suppressor cells (PMN-MDSC) and suppress microbead or lectin-induced T cell proliferation through artefactual mechanisms.
P2860
Q28077789-C34E2293-69E6-4D73-ABE5-FB76B1544DE8Q30366188-ADAD92F1-D49D-4A55-9DB0-0B6AD19C8A4BQ35137753-6D093AA2-9F64-49BD-959B-5332A4E6BAA6Q36619643-E0D19D99-C031-4ADE-95F1-8D6414E9FAD3Q36768114-BC4CDDBA-D20C-4D3C-946C-05293AB404E7Q37327905-CC60FF70-496F-4AF4-A7F2-45BCFD057FFCQ38376217-D907BAFB-2B30-4FC1-8B3A-071C5BBDE145Q38598049-D56CA885-5CA4-4606-A6E3-F315799578B0Q38766420-B6E8F3C8-F71E-4155-A13C-1E94B4D34B56Q39027739-7C28FF1B-E356-4EA2-B9F2-4B33F9EFBC05Q40057755-6A7630FF-9A99-49E5-9578-1AEEFFCD8B45Q49912213-04A12F36-AF71-4F75-A11F-AD0979A10E3F
P2860
Genetic variation in the prostaglandin E2 pathway is associated with primary graft dysfunction.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Genetic variation in the prost ...... ith primary graft dysfunction.
@en
Genetic variation in the prost ...... ith primary graft dysfunction.
@nl
type
label
Genetic variation in the prost ...... ith primary graft dysfunction.
@en
Genetic variation in the prost ...... ith primary graft dysfunction.
@nl
prefLabel
Genetic variation in the prost ...... ith primary graft dysfunction.
@en
Genetic variation in the prost ...... ith primary graft dysfunction.
@nl
P2093
P2860
P50
P1476
Genetic variation in the prost ...... with primary graft dysfunction
@en
P2093
Altaf Kazi
Ann Weinacker
Edward Cantu
Ejigayehu Demissie
James C Lee
Jonathan Orens
Joshua M Diamond
Keith Wille
Lung Transplant Outcomes Group
Maria Crespo
P2860
P304
P356
10.1164/RCCM.201307-1283OC
P407
P577
2014-03-01T00:00:00Z